In the EU, the number of approved drugs is rising with a new active ingredient; however, stagnated, the number of newly approved generics.
read at
http://www.pharmazeutische-zeitung.de/index.php?id=52016
Filed under: EU PIPELINE, EU SUBMISSION Tagged: EMA
